859 related articles for article (PubMed ID: 31344409)
1. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
Mroz MS; Harvey BJ
Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
[TBL] [Abstract][Full Text] [Related]
2. Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium.
Saint-Criq V; Kim SH; Katzenellenbogen JA; Harvey BJ
PLoS One; 2013; 8(11):e78593. PubMed ID: 24223826
[TBL] [Abstract][Full Text] [Related]
3. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
[TBL] [Abstract][Full Text] [Related]
4. Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.
Gianotti A; Melani R; Caci E; Sondo E; Ravazzolo R; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):445-52. PubMed ID: 23600628
[TBL] [Abstract][Full Text] [Related]
5. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
6. Junctional abnormalities in human airway epithelial cells expressing F508del CFTR.
Molina SA; Stauffer B; Moriarty HK; Kim AH; McCarty NA; Koval M
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(5):L475-87. PubMed ID: 26115671
[TBL] [Abstract][Full Text] [Related]
7. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art.
Althaus M
Curr Mol Pharmacol; 2013 Mar; 6(1):3-12. PubMed ID: 23547930
[TBL] [Abstract][Full Text] [Related]
8. Epithelial sodium channel inhibition in primary human bronchial epithelia by transfected siRNA.
Caci E; Melani R; Pedemonte N; Yueksekdag G; Ravazzolo R; Rosenecker J; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):211-6. PubMed ID: 18723440
[TBL] [Abstract][Full Text] [Related]
9. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.
Myerburg MM; King JD; Oyster NM; Fitch AC; Magill A; Baty CJ; Watkins SC; Kolls JK; Pilewski JM; Hallows KR
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):676-84. PubMed ID: 19617399
[TBL] [Abstract][Full Text] [Related]
10. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.
Wagner CA; Ott M; Klingel K; Beck S; Melzig J; Friedrich B; Wild KN; Bröer S; Moschen I; Albers A; Waldegger S; Tümmler B; Egan ME; Geibel JP; Kandolf R; Lang F
Cell Physiol Biochem; 2001; 11(4):209-18. PubMed ID: 11509829
[TBL] [Abstract][Full Text] [Related]
11. Ion transport mechanisms for smoke inhalation-injured airway epithelial barrier.
Chang J; Chen Z; Zhao R; Nie HG; Ji HL
Cell Biol Toxicol; 2020 Dec; 36(6):571-589. PubMed ID: 32588239
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
Kunzelmann K; Mall M
Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
[TBL] [Abstract][Full Text] [Related]
13. EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair.
Trinh NT; Privé A; Maillé E; Noël J; Brochiero E
Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L866-80. PubMed ID: 18757521
[TBL] [Abstract][Full Text] [Related]
14. cAMP triggers Na
Luan X; Le Y; Jagadeeshan S; Murray B; Carmalt JL; Duke T; Beazley S; Fujiyama M; Swekla K; Gray B; Burmester M; Campanucci VA; Shipley A; Machen TE; Tam JS; Ianowski JP
Cell Rep; 2021 Oct; 37(1):109795. PubMed ID: 34610318
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia.
Verrière V; Higgins G; Al-Alawi M; Costello RW; McNally P; Chiron R; Harvey BJ; Urbach V
PLoS One; 2012; 7(5):e37746. PubMed ID: 22662206
[TBL] [Abstract][Full Text] [Related]
16. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis.
Shei RJ; Peabody JE; Kaza N; Rowe SM
Curr Opin Pharmacol; 2018 Dec; 43():152-165. PubMed ID: 30340955
[TBL] [Abstract][Full Text] [Related]
17. SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration.
Webster MJ; Reidel B; Tan CD; Ghosh A; Alexis NE; Donaldson SH; Kesimer M; Ribeiro CMP; Tarran R
Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30190268
[TBL] [Abstract][Full Text] [Related]
18. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).
Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK
J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149
[TBL] [Abstract][Full Text] [Related]
19. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA
Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
[TBL] [Abstract][Full Text] [Related]
20. Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells.
Hendrick SM; Mroz MS; Greene CM; Keely SJ; Harvey BJ
Am J Physiol Lung Cell Mol Physiol; 2014 Sep; 307(5):L407-18. PubMed ID: 24993131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
